Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The loss of mdm2 induces p53 mediated apoptosis

Abstract

The p53 tumor suppressor gene product is negatively regulated by the product of its downstream target, mdm2. The deletion of mdm2 in the mouse results in embryonic lethality at 5.5 days post coitum (d.p.c.) which can be overcome by simultaneous loss of the p53 tumor suppressor, substantiating the importance of the negative regulatory function of MDM2 on p53 function in vivo. Hence, the loss of MDM2 allowed the unregulated p53 protein to continuously exert its growth-suppressing activity, which either led to a complete G1 arrest or induced the p53-dependent apoptotic pathway, resulting in the death of the mdm2−/− embryos. To determine which of these possibilities is occurring, mouse embryo fibroblasts (MEFs) from p53 null and p53/mdm2 double null embryos were transfected with a retroviral vector carrying a temperature-sensitive p53 (tsp53) cDNA. Shifting of single-cell clonal populations to the permissive temperature caused the p53−/−mdm2−/− fibroblasts expressing tsp53 to undergo apoptosis in a dose-dependent manner. This phenotype was not observed in the tsp53 expressing p53−/− clones nor the parental cell lines. Thus, our data indicate that the simple loss of mdm2 can induce the p53-dependent apoptotic pathway in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Baker SJ, Markowitz S, Fearon E, Willson JKV and Vogelstein B . 1990 Science 249: 912–915

  • Barak Y and Oren M . 1992 EMBO J 11: 2115–2121

  • Barak Y, Juven T, Haffner R and Oren M . 1993 EMBO J 12: 461–468

  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N . 1995 Nature 377: 646–649

  • Caron de Fromentel C and Soussi T . 1992 Genes Chrom Cancer 4: 1–15

  • Chen PL, Chen Y, Bookstein R and Lee WH . 1990 Science 250: 1576–1580

  • Chen X, Ko L, Jayaraman L and Prives C . 1996 Genes Dev 10: 2438–2451

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH . 1993 Nature 362: 849–852

  • Clarke AR, Gledhill S, Hooper ML, Bird CC and Wyllie AH . 1994 Oncogene 9: 1767–1773

  • Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ . 1994 Cancer Res 54: 794–799

  • Deffie A, Hao M, Montes de Oca Luna R, Hulboy DL and Lozano G . 1995 Mol Cell Biol 15: 3926–3933

  • Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B and Friend SH . 1990 Mol Cell Biol 10: 5772–5781

  • Donehower LA, Harvey M, Slagle B, McArthur MJ, Montgomery CA, Butel J and Bradley A . 1992 Nature 356: 215–221

  • Dulic V, Kaufmann WK, Wilson S, Tlsty T, Lees E, Harper JW, Elledge S and Reed S . 1994 Cell 76: 1013–1023

  • Fields S and Jang SK . 1990 Science 249: 1046–1049

  • Friedlander P, Haupt Y, Prives C and Oren M . 1996 Mol Cell Biol 16: 4961–4971

  • Gannon JV and Lane DP . 1991 Nature 349: 802–806

  • Ginsberg D, Michalovitz D, Ginsberg D and Oren M . 1991 Mol Cell Biol 11: 582–585

  • Gottlieb TM and Oren M . 1996 Biochim Biophys Acta 1287: 77–102

  • Gottlieb TM and Oren M . 1998 Seminars in Cancer Biology 8: 359–368

  • Gu Y, Turck CW and Morgan DO . 1993 Nature 366: 707–710

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ . 1993 Cell 75: 805–816

  • Haupt Y, Maya R, Kazaz A and Oren M . 1997 Nature 387: 296–299

  • Hollstein M, Sidransky D, Vogelstein B and Harris CC . 1991 Science 253: 49–53

  • Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y and Nagata S . 1991 Cell 66: 233–243

  • Jacks T, Remington L, Williams BO, Schmitt E, Halachmi S, Bronson RT and Weinberg RA . 1994 Curr Biol 4: 1–7

  • Johnson P, Gray D, Mowat M and Benchimol S . 1991 Mol Cell Biol 11: 1–11

  • Jones SN, Roe AE, Donehower LA and Bradley A . 1995 Nature 378: 206–208

  • Kastan MB, Radin AI, Kuerbitz SJ, Onyekwere O, Wolkow CA, Civin CI, Stone KD, Woo T, Ravindranath Y and Craig RW . 1991a Cancer Res 51: 4279–4286

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW . 1991b Cancer Res 51: 6304–6311

  • Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ . 1992 Cell 71: 587–597

  • Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B . 1991 Science 252: 1708–1711

  • Ko LJ and Prives C . 1996 Genes Dev 10: 1054–1072

  • Kubbutat M, Jones SN and Vousden KH . 1997 Nature 387: 299–303

  • Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB . 1992 Proc Natl Acad Sci USA 89: 7491–7495

  • Lin D, Shields MT, Ullrich SJ, Appella E and Mercer WE . 1992 Proc Natl Acad Sci USA 89: 9210–9214

  • Lotem J and Sachs L . 1993 Blood 82: 1092–1096

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T . 1993 Nature 362: 847–849

  • Lozano G and Montes de Oca Luna R . 1998 Biochim Biophys Acta 1377: M55–M59

  • Ludwig RL, Bates S and Vousden KH . 1996 Mol Cell Biol 16: 4952–4960

  • Marshall CJ . 1991 Cell 64: 313–326

  • Martinez J, Georgoff I, Martinez J and Levine AJ . 1991 Genes Dev 5: 151–159

  • Mayo LD, Turchi JJ and Berberich SJ . 1997 Cancer Res 57: 5013–5016

  • McMasters KM, Montes de Oca Luna R, Pena J and Lozano G . 1996 Oncogene 13: 1731–1736

  • Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW and Ullrich SJ . 1990 Proc Natl Acad Sci USA 87: 6166–6170

  • Michalovitz D, Halevy O and Oren M . 1990 Cell 62: 671–680

  • Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Hoffman B, Lieberman DA and Reed JC . 1994 Oncogene 9: 1799–1805

  • Miyashita T and Reed JC . 1995 Cell 80: 293–299

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ . 1992 Cell 69: 1237–1245

  • Momand J, Jung D, Wilezynski S and Niland J . 1998 Nuc Acids Res 26: 3453–3459

  • Montes de Oca Luna R, Wagner DS and Lozano G . 1995 Nature 378: 203–206

  • Muller AJ, Young JC, Pendergast A, Pondel M, Landau NR, Littman DR and Witte ON . 1991 Mol Cell Biol 11: 1785–1792

  • Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M and Krammer PH . 1998 J Exp Med 188: 2033–2045

  • Okamoto K and Beach D . 1994 EMBO J 13: 4816–4822

  • Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B . 1992 Nature 358: 80–83

  • Oliner JD, Pietenpol JA, Thiagalingam S, Guyris J, Kinzler K and Vogelstein B . 1993 Nature 362: 857–860

  • Owen-Schaub L, Zhang W, Cusack JC, Angelo LS, Santee S, Fujiwara T, Roth Deisseroth A, Zhang W, Kruzel E and Radinsky R . 1995 Mol Cell Biol 15: 3032–3040

  • Pear WS, Nolan GP, Scott ML and Baltimore D . 1993 Proc Natl Acad Sci USA 90: 8392–8396

  • Piette J, Neel H and Marechal V . 1997 Oncogene 15: 1001–1010

  • Raycroft L, Wu H and Lozano G . 1990 Science 249: 1049–1051

  • Raycroft L, Schmidt JR, Yoas K, Hao M and Lozano G . 1991 Mol Cell Biol 11: 6067–6074

  • Ryan JJ, Danish R, Gottlieb CA and Clarke MF . 1993 Mol Cell Biol 13: 711–719

  • Shieh SY, Ikeda M, Taya Y and Prives C . 1997 Cell 91: 325–334

  • Sheikh MS, Shao Z, Hussain A and Fontana J . 1993 Cancer Res 53: 3226–3228

  • Tishler RB, Calderwood SK, Coleman CN and Price BD . 1993 Cancer Res 53: 2212–2216

  • Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M, Koh T, Ariyasu T, Tachi M, Kasuga M and Takahashi R . 1995 Oncogene 11: 1939–1946

  • Wu X, Bayle JH, Olson D and Levine AJ . 1993 Genes Dev 7: 1126–1132

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D . 1993 Nature 366: 701–704

  • Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M . 1991 Nature 352: 345–347

  • Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P and Oren M . 1993 Mol Cell Biol 13: 1415–1423

  • Zauberman A, Lupo A and Oren M . 1995 Oncogene 10: 2361–2366

Download references

Acknowledgements

We thank Sylvie Wilder for expert technical assistance and Susan Evans and Mini Kapoor for constructive criticism and advice on the manuscript. This work was supported by grants from the NCI (CA47296) to G Lozano and (CA40099) to M Oren and in part from funds for The Faculty Achievement Award in Basic Research to G Lozano.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Rozieres, S., Maya, R., Oren, M. et al. The loss of mdm2 induces p53 mediated apoptosis. Oncogene 19, 1691–1697 (2000). https://doi.org/10.1038/sj.onc.1203468

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203468

Keywords

This article is cited by

Search

Quick links